US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
Influenza and other respiratory illnesses, including COVID-19, are important causes of morbidity, mortality, and healthcare burden across all age groups.
For influenza and novel vaccines, such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed in order to evaluate the protection provided by nationwide vaccination programs.
The goal of this notice of funding opportunity is to support a network of US institutions that can:
a) conduct systematic testing for laboratory-confirmed disease due to influenza, SARS-CoV-2 and other respiratory virus infections, b) obtain reliable vaccination information for enrolled patients and c) provide accurate estimates of the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2 and other respiratory viruses, to prevent medically attended influenza-associated illness in the population for whom vaccination is recommended.
For influenza and novel vaccines, such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed in order to evaluate the protection provided by nationwide vaccination programs.
The goal of this notice of funding opportunity is to support a network of US institutions that can:
a) conduct systematic testing for laboratory-confirmed disease due to influenza, SARS-CoV-2 and other respiratory virus infections, b) obtain reliable vaccination information for enrolled patients and c) provide accurate estimates of the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2 and other respiratory viruses, to prevent medically attended influenza-associated illness in the population for whom vaccination is recommended.
Related Programs
Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Rel
Department of Health and Human ServicesImmunization Research, Demonstration, Public Information and Education_Training and Clinical Skills
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $107,500,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $107,500,000
Who's Eligible
Obtain Full Opportunity Text:
Complete solicitation information
Additional Information of Eligibility:
N/A
Full Opportunity Web Address:
https://nspires.nasaprs.com/external/solicitations/summary.do?solId={FC8AA32D-180F-9B49-AE48-7C30FCD68E9B}&path=&method=init
Contact:
Agency Email Description:
AYang@cdc.gov
Agency Email:
Date Posted:
2022-03-08
Application Due Date:
Archive Date:
2022-06-03
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
